← Back to Clinical Trials
Recruiting Phase 3 NCT06463379
The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis
Trial Parameters
Condition Refractory Juvenile Idiopathic Arthritis (Despite 2 DMARDs Still Active)
Sponsor Sohag University
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 215
Sex ALL
Min Age 2 Years
Max Age 18 Years
Start Date 2024-05-01
Completion 2024-08-31
Interventions
Solumedrol
Brief Summary
Interventional phase 3 study aiming to unravel the value of pulse steroids in achieving remission or low disease activity in refractory active JIA
Eligibility Criteria
Inclusion Criteria: * Patients still active despite administration o 2 DMARDs Exclusion Criteria: * Other connective tissue diseases * Endocrine disorders such as Thyroid disorders.